Efficacy, safety, and biodistribution of intranasally delivered adenoviral COVID-19 vaccine in hamsters

npj Vaccines · Published 2026-08-01 · DOI 10.1038/s41541-026-01543-4

Free full text

Authors (22)

N. Laham-Karam, P. Mäkinen, E. Koivulehto, E. Gurzeler, A. Sormunen, A. Tawfek, T. Suomalainen, R. Fagerlund, EA Niskanen, H. Uğurlu, J. Virkkala, J. Rodon, G. Cantero, N. Roca, T. Kekarainen, E. Ylösmäki, J. Vergara-Alert, TL Freitag, J. Segalés, K. Alitalo, K. Saksela, S. Ylä-Herttuala

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Laham-Karam, N., Mäkinen, P., Koivulehto, E., et al. (2026). Efficacy, safety, and biodistribution of intranasally delivered adenoviral COVID-19 vaccine in hamsters. npj Vaccines. https://doi.org/10.1038/s41541-026-01543-4

Related articles

• Maturation-deficient chikungunya virus elicits protective immune responses in a murine challenge model · npj Vaccines · 2026 · Same journal
• Recent advances in Epstein–Barr virus vaccines development from mechanistic exploration to clinical translation · npj Vaccines · 2026 · Same journal
• Maternal influenza vaccination boosts durable breast milk antibody-mediated protection in infants · npj Vaccines · 2026 · Same journal
• Vaccination in individuals with Down syndrome: immune vulnerability, safety, efficacy and opportunities · npj Vaccines · 2026 · Same journal
• Preserved SARS-CoV-2 T-cell responses despite impaired humoral immunity in children with profound B-cell lymphopenia · npj Vaccines · 2026 · Same journal
• Suppressor tRNA-mediated conditionally replicating live vaccine effectively protects pigs against Seneca Valley virus challenge · npj Vaccines · 2026 · Same journal
• Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy · npj Vaccines · 2026 · Same journal
• Post-exposure vaccination with an adjuvanted protein subunit vaccine, but not BCG, protects mice and guinea pigs against M. tuberculosis · npj Vaccines · 2026 · Same journal
• Multiorgan Outcomes Following BNT162b2 mRNA Vaccination vs SARS-CoV-2 Infection: A 30-Million-Person Real-World Cohort Analysis · npj Vaccines · 2026 · Same journal
• Safety and immunogenicity testing of a melioidosis subunit vaccine candidate in cynomolgus macaques · npj Vaccines · 2026 · Same journal